Age-associated loss of immunomodulatory protection by granulocyte-colony stimulating factor in endotoxic rats

Shock

Volumn 18, Issue 4, 2002, Pages 348-354

  Vollmar, Brigitte ^a   Pradarutti, Sascha ^a   Nickels, Ruth M ^a   Menger, Michael D ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cytokines; Immunomodulators; In vivo animal models; Inflammation; Rodent

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; LIPOPOLYSACCHARIDE;

AGING; ANIMAL; ARTICLE; BILE; BLOOD; DRUG EFFECT; ENDOTOXEMIA; IMMUNOLOGY; KUPFFER CELL; LIVER; LIVER CIRCULATION; MALE; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE; CYTOKINES; ENDOTOXEMIA; GRANULOCYTE COLONY-STIMULATING FACTOR; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRCULATION; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR;

EID: 0036780367     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200210000-00010     Document Type: Article

References (44)

1. Berk SL, Smith JK: Infectious diseases in the elderly. Med Clin North Am 67:273-293, 1983.
2. Finkelstein MS, Petkun WM, Freedman ML, Antopol SC: Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 31:19-27, 1983.
3. Saltzman RL, Peterson PK: Immunodeficiency of the elderly. Rev Infect Dis 9:1127-1139, 1987.
4. Thoman ML, Weigle WO: The cellular and subcellular basis of immunosenescence. In: Dixon FJ (ed): Advances in Immunology. San Diego: Academic Press, Vol 46, 1989, pp 221-261.
5. Miller RA: The cell biology of aging: immunological models. J Gerontol 44:B4-B8, 1989.
6. Chorinchath BB, Kong LY, Mao L, McCallum RE: Age-associated differences in TNF-α and nitric oxide production in endotoxic mice. J Immunol 156:1525-1530, 1996.
7. Yamano T, Shimizu M, Noda T: Age-related change in cadmium-induced hepatotoxicity in Wistar rats: role of Kupffer cells and neutrophils. Toxicol Appl Pharmacol 151:9-15, 1998.
8. Knook DL, Brouwer A: Kupffer cells and the acute phase response: the effect of aging. Immunol Invest 18:339-350, 1989.
9. Gutsmann-Conrad A, Pahlavani MA, Heydari AR, Richardson A: Expression of heat shock protein 70 decreases with age in hepatocytes and splenocytes from female rats. Mech Ageing Dev 107:255-270, 1999.
10. Moore MA: The clinical use of colony stimulating factors. Annu Rev Immunol 9:159-191, 1991.
11. Roilides E, Pizzo PA: Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 15:508-524, 1992.
12. Gillan E, Plunkett M, Cairo MS: Colony-stimulating factors in the modulation of sepsis. New Horiz 1:96-109, 1993.
13. Cairo MS, Plunkett JM, Nguyen A, van de Ven C: Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis. Blood 80:96-101, 1992.
14. Fink MP, O'Sullivan BP, Menconi MJ, Wollert SP, Wang H, Youssef ME, Bellelsle JM: Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 34:571-577, 1993.
15. Lang CH, Bagby GJ, Dobrescu C, Nelson S, Spitzer JJ: Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis 166:336-343, 1992.
16. Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffman WD, Banks SM, MacVittie TJ: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 77:2366-2373, 1994.
17. Haberstroh J, Breuer H, Lücke I, Massarrat K, Früh R, Mand U, Hagedorn P, Brunnberg L, von Specht BU: Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis. Shock 4:216-224, 1995.
18. Barsig J, Bundschuh DS, Hartung T, Bauhofer A, Sauer A, Wendel A: Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis 174:790-799, 1996.
19. Vollmar B, Messner S, Wanner GA, Hartung T, Menger MD: Immunomodulatory action of G-CSF in a rat model of endotoxin-induced liver injury: an intravital microscopic analysis of Kupffer cell and leukocyte response. J Leukocyte Biol 62:710-718, 1997.
20. Gross-Weege W, Weiss M, Schneider M, Wenning M, Harms B, Dumon K, Ohmann C, Röher HD: Safety of a low-dosage Filgrastim (rhG-CSF) treatment in non-neutropenic surgical intensive care patients with an inflammatory process. Intensive Care Med 23:16-22, 1997.
21. Djaiani G, Ridley S: Outcome of intensive care in the elderly. Anaesthesia 52:1130-1136, 1997.
22. Baker HJ, Lindsey RJ, Weisbroth SH: The Laboratory Rat. New York: Academic Press, Vol 1 and 2, 1979.
23. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD: Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145:1421-1431, 1994.
24. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K: Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 267:G786-G793, 1994.
25. Vollmar B, Glasz J, Post S, Menger MD: Depressed phagocytic activity of Kupffer cells after warm ischemia-reperfusion of the liver. J Hepatol 20:301-304, 1994.
26. Vollmar B, Rüttinger D, Wanner GA, Leiderer R, Menger MD: Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock 6:434-441, 1996.
27. Zeintl H, Tompkins WR, Messmer K, Intaglietta M: Static and dynamic microcirculatory video image analysis applied to clinical investigations. Prog Appl Microcirc 11:1-10, 1986.
28. Vollmar B, Siegmund S, Menger MD: An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Hepatology 27:1544-1553, 1998.
29. Yoshikawa TT: Geriatric infectious diseases: an emerging problem. J Am Geriat Soc 31:34-39, 1983.
30. Gladstone JL, Recco R: Host factors and infectious diseases in the elderly. Med Clin North Am 60:1225-1240, 1976.
31. Giroir BP: Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 21:780-789, 1993.
32. Windsor ACJ, Walsh CJ, Mullen PG, Cook DJ, Fisher BJ, Blocher CR, Leeper-Woodford SK, Sugarman HJ, Fowler III AA: Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 91:1459-1468, 1993.
33. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338, 1989.
34. Waage A, Espevik T: Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med 167:1987-1992, 1988.
35. Hyde SR, McCallum RE: Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun 60:976-982, 1992.
36. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23:2375-2378, 1993.
37. Gamelli RL, He LK, Liu H: Recombinant human granulocyte colony-stimulating factor treatment improves macrophage suppression of granulocyte and macrophage growth after burn and burn wound infection. J Trauma 39: 1141-1146, 1995.
38. Hartung T, Döcke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482-2489, 1995.
39. Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A: Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24:1167-1171, 1994.
40. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155:2222-2229, 1995.
41. Sadeghi S, Wallace FA, Calder PC: Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96:404-410, 1999.
42. Wanner GA, Stöckle V, Bauer M, Menger MD, Vollmar B: Differential gene expression of CINC, NOS II, and ICAM-1 in endotoxemic liver cells by rG-CSF. Langenbecks Arch Surg 384:216-221, 1999.
43. Price TH, Chatta GS, Dale DC: Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335-340, 1996.
44. Hollenstein U, Homoncik M, Stohlawetz PJ, Marsik C, Sieder A, Eichler HG, Jilma B: Endotoxin down-modulates granulocyte colony-stimulating factor receptor (CD114) on human neutrophils. J Infect Dis 182:343-346, 2000.